Validation of the standardization framework SSTR-RADS 1.0 for neuroendocrine tumors using the novel SSTR‑targeting peptide [18F]SiTATE.
Ebner R, Lohse A, Fabritius MP, Rübenthaler J, Wängler C, Wängler B, Schirrmacher R, Völter F, Schmid HP, Unterrainer LM, Öcal O, Hinterberger A, Spitzweg C, Auernhammer CJ, Geyer T, Ricke J, Bartenstein P, Holzgreve A, Grawe F.
Ebner R, et al. Among authors: schmid hp.
Eur Radiol. 2024 May 20. doi: 10.1007/s00330-024-10788-3. Online ahead of print.
Eur Radiol. 2024.
PMID: 38769164